Alpha Teknova, Inc. (TKNO)
3.32
-0.38
(-10.27%)
USD |
NASDAQ |
Jan 16, 16:00
3.38
+0.06
(+1.81%)
Pre-Market: 20:00
Alpha Teknova EPS Diluted (Quarterly): -0.0801 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Puma Biotechnology, Inc. | 0.1736 |
| Nephros, Inc. | 0.0305 |
| Spero Therapeutics, Inc. | -0.1312 |
| Pyxis Oncology, Inc. | -0.3517 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.286M |
| Revenue (Quarterly) | 10.45M |
| Total Expenses (Quarterly) | 14.74M |
| Enterprise Value | 184.58M |
| Gross Profit Margin (Quarterly) | 27.92% |
| Profit Margin (Quarterly) | -41.00% |
| Earnings Yield | -10.27% |
| Normalized Earnings Yield | -10.27 |